i

i2020 Accelerator

3 employees

The i2020 Accelerator will provide funding and resources to companies in the areas of inflammation, oncology, CNS, and infectious diseases

Basic info

biotechnology research

flexible partnering business models

biotechnology

early drug discovery

agile science programming

target to advanced lead and clinical candidate

small molecules

2018